Загрузка...
The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial
BACKGROUND: Dementia is a large and growing health care burden globally, and its major cause is Alzheimer's disease (AD). MLC901 (Neuroaid II) is a simplified form of MLC601 (Neuroaid), a Traditional Chinese Medicine with neuroprotective and neuroproliferative properties in cellular and animal...
Сохранить в:
| Опубликовано в: : | Alzheimers Dement (N Y) |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6352850/ https://ncbi.nlm.nih.gov/pubmed/30723778 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2018.12.001 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|